(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Edgewise Therapeutics, Inc. Insider Trading
* In original currency USD
Loading Data
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Wednesday, January 21st, 2026 | Edris Badreddin | director | 135,291 | M-Exempt | A | 7,605 | 0.71 USD | 5,400 USD |
| Wednesday, January 21st, 2026 | Edris Badreddin | director | 127,686 | M-Exempt | A | 66,477 | 1.93 USD | 128,301 USD |
| Wednesday, January 21st, 2026 | Edris Badreddin | director | 121,601 | S-Sale | D | 13,690 | 29.44 USD | 403,034 USD |
| Wednesday, January 21st, 2026 | Edris Badreddin | director | 104,365 | S-Sale | D | 17,236 | 29.44 USD | 507,428 USD |
| Wednesday, January 21st, 2026 | Edris Badreddin | director | 96,760 | S-Sale | D | 7,605 | 29.44 USD | 223,891 USD |
| Wednesday, January 21st, 2026 | Edris Badreddin | director | 86,297 | S-Sale | D | 10,463 | 29.44 USD | 308,031 USD |
| Wednesday, January 21st, 2026 | Edris Badreddin | director | 61,209 | M-Exempt | A | 10,463 | 1.93 USD | 20,194 USD |
| Wednesday, January 21st, 2026 | Edris Badreddin | director | 50,746 | M-Exempt | A | 17,236 | 0.64 USD | 11,031 USD |
| Wednesday, January 21st, 2026 | Edris Badreddin | director | 33,510 | M-Exempt | A | 13,690 | 0.39 USD | 5,339 USD |
| Wednesday, January 21st, 2026 | Edris Badreddin | director | 19,820 | S-Sale | D | 66,477 | 29.44 USD | 1,957,083 USD |
| Wednesday, January 21st, 2026 | Edris Badreddin | director | 0 | M-Exempt | D | 66,477 | 1.93 USD | 128,301 USD |
| Wednesday, January 21st, 2026 | Edris Badreddin | director | 0 | M-Exempt | D | 17,236 | 0.64 USD | 11,031 USD |
| Wednesday, January 21st, 2026 | Edris Badreddin | director | 0 | M-Exempt | D | 7,605 | 0.71 USD | 5,400 USD |
| Wednesday, January 21st, 2026 | Edris Badreddin | director | 0 | M-Exempt | D | 13,690 | 0.39 USD | 5,339 USD |
| Friday, January 2nd, 2026 | Fox Jonathan C | director | 24,175 | A-Award | A | 473 | 0.00 USD | 0 USD |
| Wednesday, November 19th, 2025 | Martin Christopher Nathan | director | 45,150 | A-Award | A | 45,150 | 22.34 USD | 1,008,651 USD |
| Wednesday, November 19th, 2025 | Martin Christopher Nathan | 0 | 0 | 0.00 USD | 0 USD | |||
| Wednesday, November 12th, 2025 | Russell Alan J | director, officer: Chief Scientific Officer | 1,147,365 | M-Exempt | D | 100,000 | 0.18 USD | 18,000 USD |
| Wednesday, November 12th, 2025 | Russell Alan J | director, officer: Chief Scientific Officer | 123,400 | M-Exempt | A | 100,000 | 0.18 USD | 18,000 USD |
| Wednesday, November 12th, 2025 | Russell Alan J | director, officer: Chief Scientific Officer | 23,400 | S-Sale | D | 100,000 | 21.12 USD | 2,112,450 USD |
| Tuesday, November 11th, 2025 | Fox Jonathan C | director | 23,702 | P-Purchase | A | 10,700 | 18.64 USD | 199,403 USD |
| Monday, November 10th, 2025 | Nofi Michael | officer: Chief Financial Officer | 262,500 | A-Award | A | 262,500 | 18.28 USD | 4,798,500 USD |
| Monday, November 10th, 2025 | Nofi Michael | officer: Chief Financial Officer | 43,750 | A-Award | A | 43,750 | 0.00 USD | 0 USD |
| Monday, November 10th, 2025 | Nofi Michael | 0 | 0 | 0.00 USD | 0 USD | |||
| Wednesday, October 1st, 2025 | Fox Jonathan C | director | 13,002 | A-Award | A | 728 | 0.00 USD | 0 USD |
| Tuesday, August 26th, 2025 | Russell Alan J | director, officer: Chief Scientific Officer | 1,247,365 | M-Exempt | D | 100,000 | 0.18 USD | 18,000 USD |
| Tuesday, August 26th, 2025 | Russell Alan J | director, officer: Chief Scientific Officer | 123,400 | M-Exempt | A | 100,000 | 0.18 USD | 18,000 USD |
| Tuesday, August 26th, 2025 | Russell Alan J | director, officer: Chief Scientific Officer | 23,400 | S-Sale | D | 100,000 | 14.60 USD | 1,459,760 USD |
| Tuesday, August 12th, 2025 | Blaustein Robert | officer: Chief Development Officer | 105,000 | A-Award | A | 105,000 | 13.39 USD | 1,405,950 USD |
| Tuesday, August 12th, 2025 | Blaustein Robert | officer: Chief Development Officer | 17,500 | A-Award | A | 17,500 | 0.00 USD | 0 USD |
| Tuesday, August 12th, 2025 | MOORE JOHN R | officer: General Counsel | 161,250 | A-Award | A | 161,250 | 13.39 USD | 2,159,138 USD |
| Tuesday, August 12th, 2025 | MOORE JOHN R | officer: General Counsel | 26,875 | A-Award | A | 26,875 | 0.00 USD | 0 USD |
| Tuesday, August 12th, 2025 | MOORE JOHN R | officer: General Counsel | 17,344 | M-Exempt | D | 5,781 | 0.00 USD | 0 USD |
| Tuesday, August 12th, 2025 | MOORE JOHN R | officer: General Counsel | 12,312 | M-Exempt | A | 5,781 | 0.00 USD | 0 USD |
| Tuesday, August 12th, 2025 | MOORE JOHN R | officer: General Counsel | 10,214 | S-Sale | D | 2,098 | 13.39 USD | 28,097 USD |
| Tuesday, August 12th, 2025 | Derakhshan Behrad | officer: Chief Business Officer | 180,000 | A-Award | A | 180,000 | 13.39 USD | 2,410,200 USD |
| Tuesday, August 12th, 2025 | Derakhshan Behrad | officer: Chief Business Officer | 30,000 | A-Award | A | 30,000 | 0.00 USD | 0 USD |
| Tuesday, August 12th, 2025 | Derakhshan Behrad | officer: Chief Business Officer | 26,136 | M-Exempt | A | 5,781 | 0.00 USD | 0 USD |
| Tuesday, August 12th, 2025 | Derakhshan Behrad | officer: Chief Business Officer | 23,645 | S-Sale | D | 2,491 | 13.39 USD | 33,361 USD |
| Tuesday, August 12th, 2025 | Derakhshan Behrad | officer: Chief Business Officer | 17,344 | M-Exempt | D | 5,781 | 0.00 USD | 0 USD |
| Tuesday, August 12th, 2025 | Carruthers R Michael | officer: Chief Financial Officer | 161,250 | A-Award | A | 161,250 | 13.39 USD | 2,159,138 USD |
| Tuesday, August 12th, 2025 | Carruthers R Michael | officer: Chief Financial Officer | 87,590 | M-Exempt | A | 5,781 | 0.00 USD | 0 USD |
| Tuesday, August 12th, 2025 | Carruthers R Michael | officer: Chief Financial Officer | 86,162 | S-Sale | D | 1,428 | 13.39 USD | 19,124 USD |
| Tuesday, August 12th, 2025 | Carruthers R Michael | officer: Chief Financial Officer | 26,875 | A-Award | A | 26,875 | 0.00 USD | 0 USD |
| Tuesday, August 12th, 2025 | Carruthers R Michael | officer: Chief Financial Officer | 17,344 | M-Exempt | D | 5,781 | 0.00 USD | 0 USD |
| Tuesday, August 12th, 2025 | Russell Alan J | director, officer: Chief Scientific Officer | 168,750 | A-Award | A | 168,750 | 13.39 USD | 2,259,563 USD |
| Tuesday, August 12th, 2025 | Russell Alan J | director, officer: Chief Scientific Officer | 28,125 | A-Award | A | 28,125 | 0.00 USD | 0 USD |
| Tuesday, August 12th, 2025 | Russell Alan J | director, officer: Chief Scientific Officer | 25,307 | M-Exempt | A | 5,781 | 0.00 USD | 0 USD |
| Tuesday, August 12th, 2025 | Russell Alan J | director, officer: Chief Scientific Officer | 23,400 | S-Sale | D | 1,907 | 13.39 USD | 25,539 USD |
| Tuesday, August 12th, 2025 | Russell Alan J | director, officer: Chief Scientific Officer | 17,344 | M-Exempt | D | 5,781 | 0.00 USD | 0 USD |
| Tuesday, August 12th, 2025 | KOCH KEVIN | director, officer: President and CEO | 525,000 | A-Award | A | 525,000 | 13.39 USD | 7,029,750 USD |
| Tuesday, August 12th, 2025 | KOCH KEVIN | director, officer: President and CEO | 87,500 | A-Award | A | 87,500 | 0.00 USD | 0 USD |
| Tuesday, August 12th, 2025 | KOCH KEVIN | director, officer: President and CEO | 53,907 | M-Exempt | D | 17,968 | 0.00 USD | 0 USD |
| Tuesday, August 12th, 2025 | KOCH KEVIN | director, officer: President and CEO | 38,587 | M-Exempt | A | 17,968 | 0.00 USD | 0 USD |
| Tuesday, August 12th, 2025 | KOCH KEVIN | director, officer: President and CEO | 30,615 | S-Sale | D | 7,972 | 13.39 USD | 106,764 USD |
| Tuesday, August 12th, 2025 | Donovan Joanne M. | officer: CMO | 168,750 | A-Award | A | 168,750 | 13.39 USD | 2,259,563 USD |
| Tuesday, August 12th, 2025 | Donovan Joanne M. | officer: CMO | 28,223 | M-Exempt | A | 5,781 | 0.00 USD | 0 USD |
| Tuesday, August 12th, 2025 | Donovan Joanne M. | officer: CMO | 28,125 | A-Award | A | 28,125 | 0.00 USD | 0 USD |
| Tuesday, August 12th, 2025 | Donovan Joanne M. | officer: CMO | 25,361 | S-Sale | D | 2,862 | 13.39 USD | 38,329 USD |
| Tuesday, August 12th, 2025 | Donovan Joanne M. | officer: CMO | 17,344 | M-Exempt | D | 5,781 | 0.00 USD | 0 USD |
| Tuesday, July 1st, 2025 | Fox Jonathan C | director | 12,274 | A-Award | A | 858 | 0.00 USD | 0 USD |
| Monday, June 16th, 2025 | Brege Laura | director | 30,000 | A-Award | A | 30,000 | 14.68 USD | 440,400 USD |
| Monday, June 16th, 2025 | Edris Badreddin | director | 30,000 | A-Award | A | 30,000 | 14.68 USD | 440,400 USD |
| Monday, June 16th, 2025 | Fox Jonathan C | director | 30,000 | A-Award | A | 30,000 | 14.68 USD | 440,400 USD |
| Monday, June 16th, 2025 | Morris Arlene | director | 30,000 | A-Award | A | 30,000 | 14.68 USD | 440,400 USD |
| Monday, June 16th, 2025 | ROOT JONATHAN D | director | 30,000 | A-Award | A | 30,000 | 14.68 USD | 440,400 USD |
| Monday, June 16th, 2025 | Thompson Peter A. | director, 10 percent owner: | 30,000 | A-Award | A | 30,000 | 14.68 USD | 440,400 USD |
| Thursday, May 1st, 2025 | Russell Alan J | director, officer: Chief Scientific Officer | 20,072 | M-Exempt | A | 5,209 | 0.00 USD | 0 USD |
| Friday, May 2nd, 2025 | Russell Alan J | director, officer: Chief Scientific Officer | 18,521 | S-Sale | D | 1,551 | 16.45 USD | 25,521 USD |
| Thursday, May 1st, 2025 | Russell Alan J | director, officer: Chief Scientific Officer | 0 | M-Exempt | D | 5,209 | 0.00 USD | 0 USD |
| Thursday, May 1st, 2025 | MOORE JOHN R | officer: General Counsel | 8,461 | M-Exempt | A | 5,209 | 0.00 USD | 0 USD |
| Friday, May 2nd, 2025 | MOORE JOHN R | officer: General Counsel | 6,531 | S-Sale | D | 1,930 | 16.45 USD | 31,757 USD |
| Thursday, May 1st, 2025 | MOORE JOHN R | officer: General Counsel | 0 | M-Exempt | D | 5,209 | 0.00 USD | 0 USD |
| Thursday, May 1st, 2025 | KOCH KEVIN | director, officer: President and CEO | 24,895 | M-Exempt | A | 10,417 | 0.00 USD | 0 USD |
| Friday, May 2nd, 2025 | KOCH KEVIN | director, officer: President and CEO | 20,619 | S-Sale | D | 4,276 | 16.45 USD | 70,358 USD |
| Thursday, May 1st, 2025 | KOCH KEVIN | director, officer: President and CEO | 0 | M-Exempt | D | 10,417 | 0.00 USD | 0 USD |
| Thursday, May 1st, 2025 | Donovan Joanne M. | officer: CMO | 26,775 | M-Exempt | A | 10,417 | 0.00 USD | 0 USD |
| Friday, May 2nd, 2025 | Donovan Joanne M. | officer: CMO | 21,588 | S-Sale | D | 5,187 | 16.45 USD | 85,348 USD |
| Thursday, May 1st, 2025 | Donovan Joanne M. | officer: CMO | 0 | M-Exempt | D | 10,417 | 0.00 USD | 0 USD |
| Thursday, May 1st, 2025 | Derakhshan Behrad | officer: Chief Business Officer | 22,046 | M-Exempt | A | 5,209 | 0.00 USD | 0 USD |
| Friday, May 2nd, 2025 | Derakhshan Behrad | officer: Chief Business Officer | 20,355 | S-Sale | D | 1,691 | 16.45 USD | 27,824 USD |
| Thursday, May 1st, 2025 | Derakhshan Behrad | officer: Chief Business Officer | 0 | M-Exempt | D | 5,209 | 0.00 USD | 0 USD |
| Thursday, May 1st, 2025 | Carruthers R Michael | officer: Chief Financial Officer | 82,328 | M-Exempt | A | 5,209 | 0.00 USD | 0 USD |
| Friday, May 2nd, 2025 | Carruthers R Michael | officer: Chief Financial Officer | 81,014 | S-Sale | D | 1,314 | 16.45 USD | 21,621 USD |
| Thursday, May 1st, 2025 | Carruthers R Michael | officer: Chief Financial Officer | 0 | M-Exempt | D | 5,209 | 0.00 USD | 0 USD |
| Thursday, April 3rd, 2025 | Thompson Peter A. | director, 10 percent owner: | 14,809,075 | P-Purchase | A | 372,578 | 20.13 USD | 7,499,995 USD |
| Thursday, April 3rd, 2025 | Thompson Peter A. | director, 10 percent owner: | 443,792 | P-Purchase | A | 124,193 | 20.13 USD | 2,500,005 USD |
| Thursday, April 3rd, 2025 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 14,809,075 | P-Purchase | A | 372,578 | 20.13 USD | 7,499,995 USD |
| Thursday, April 3rd, 2025 | ORBIMED ADVISORS LLC | director, 10 percent owner: | 443,792 | P-Purchase | A | 124,193 | 20.13 USD | 2,500,005 USD |
| Tuesday, April 1st, 2025 | Fox Jonathan C | director | 11,416 | A-Award | A | 559 | 0.00 USD | 0 USD |
| Friday, March 7th, 2025 | Russell Alan J | director, officer: Chief Scientific Officer | 1,456,580 | M-Exempt | D | 200 | 0.18 USD | 36 USD |
| Friday, March 7th, 2025 | Russell Alan J | director, officer: Chief Scientific Officer | 15,063 | M-Exempt | A | 200 | 0.18 USD | 36 USD |
| Friday, March 7th, 2025 | Russell Alan J | director, officer: Chief Scientific Officer | 14,863 | S-Sale | D | 200 | 30.02 USD | 6,004 USD |
| Friday, March 7th, 2025 | KOCH KEVIN | director, officer: President and CEO | 41,545 | M-Exempt | D | 100 | 0.18 USD | 18 USD |
| Friday, March 7th, 2025 | KOCH KEVIN | director, officer: President and CEO | 14,578 | M-Exempt | A | 100 | 0.18 USD | 18 USD |
| Friday, March 7th, 2025 | KOCH KEVIN | director, officer: President and CEO | 14,478 | S-Sale | D | 100 | 30.00 USD | 3,000 USD |
| Wednesday, February 5th, 2025 | Russell Alan J | director, officer: Chief Scientific Officer | 1,348,765 | M-Exempt | D | 8,015 | 0.18 USD | 1,443 USD |
| Thursday, February 6th, 2025 | Russell Alan J | director, officer: Chief Scientific Officer | 1,347,565 | M-Exempt | D | 1,200 | 0.18 USD | 216 USD |
| Wednesday, February 5th, 2025 | Russell Alan J | director, officer: Chief Scientific Officer | 22,878 | M-Exempt | A | 8,015 | 0.18 USD | 1,443 USD |
| Thursday, February 6th, 2025 | Russell Alan J | director, officer: Chief Scientific Officer | 16,063 | M-Exempt | A | 1,200 | 0.18 USD | 216 USD |
